Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma-Reference-Cited by-同舟云学术

Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma

Published:2014-09-10 Issue:11 Volume:27 Page:1333-1345
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR Biomed.

Author:

Delgado-Goñi Teresa¹²³,Julià-Sapé Margarida²¹⁴^ORCID,Candiota Ana Paula²¹⁴,Pumarola Martí⁵,Arús Carles¹²⁴

Affiliation:

1. Departament de Bioquímica i Biologia Molecular, Unitat de Bioquímica de Biociències; Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

2. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN); Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

3. Cancer Research UK and EPSRC Cancer Imaging Centre, Division of Radiotherapy and Imaging; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust; Sutton Surrey SM2 5PT UK

4. Institut de Biotecnologia i de Biomedicina; Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

5. Departament de Medicina i Cirurgia Animals; Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

Funder

CIBER-BBN

Instituto de Salud Carlos III

MICINN

Publisher

Wiley

Subject

Spectroscopy,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference73 articles.

1. Glioblastoma in adults;Brandes;Crit. Rev. Oncol. Hematol.,2008